TG THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
TG THERAPEUTICS, INC. (TGTX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of -$24.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-04.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2023-08-04
- TG THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2023-06-30 was $186.00K.
- TG THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2023-03-31 was -$210.00K.
- TG THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2022-12-31 was -$147.00K.
- TG THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2022-09-30 was -$498.00K.
- TG THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2022 was -$1.19M.
- TG THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2021 was -$1.60M.
- TG THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2020 was -$228.00K.
- TG THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2019 was -$801.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$24.00K 10-Q · filed 2023-08-04 | -$171.00K derived: sum of 3 quarters · filed 2023-08-04 | -$669.00K derived: sum of 4 quarters · filed 2023-08-04 | |
| 2023-03-31 | -$210.00K 10-Q · filed 2023-05-08 | -$357.00K derived: sum of 2 quarters · filed 2023-05-08 | -$855.00K derived: sum of 3 quarters · filed 2023-05-08 | -$960.00K derived: sum of 4 quarters · filed 2023-05-08 | |
| 2022-12-31 | -$147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$645.00K derived: sum of 2 quarters · filed 2023-03-01 | -$750.00K derived: sum of 3 quarters · filed 2023-03-01 | -$1.19M 10-K · filed 2023-03-01 | |
| 2022-09-30 | -$498.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$603.00K derived: sum of 2 quarters · filed 2022-11-09 | -$1.04M 10-Q · filed 2022-11-09 | -$1.56M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2022-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$545.00K 10-Q · filed 2022-08-09 | -$1.07M derived: sum of 3 quarters · filed 2023-03-01 | -$1.42M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2022-03-31 | -$440.00K 10-Q · filed 2022-05-10 | -$962.00K derived: sum of 2 quarters · filed 2023-03-01 | -$1.31M derived: sum of 3 quarters · filed 2023-03-01 | -$1.73M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-12-31 | -$522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$875.00K derived: sum of 2 quarters · filed 2023-03-01 | -$1.29M derived: sum of 3 quarters · filed 2023-03-01 | -$1.60M 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$353.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$771.00K derived: sum of 2 quarters · filed 2021-11-08 | -$1.08M 10-Q · filed 2021-11-08 | -$864.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2021-06-30 | -$418.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$726.00K 10-Q · filed 2021-08-06 | -$511.00K derived: sum of 3 quarters · filed 2022-03-01 | -$623.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2021-03-31 | -$308.00K 10-Q · filed 2021-05-10 | -$93.00K derived: sum of 2 quarters · filed 2022-03-01 | -$205.00K derived: sum of 3 quarters · filed 2022-03-01 | -$279.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $103.00K derived: sum of 2 quarters · filed 2022-03-01 | $29.00K derived: sum of 3 quarters · filed 2022-03-01 | -$228.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$186.00K derived: sum of 2 quarters · filed 2020-11-09 | -$443.00K 10-Q · filed 2020-11-09 | -$582.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2020-06-30 | -$74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$331.00K 10-Q · filed 2020-08-10 | -$470.00K derived: sum of 3 quarters · filed 2021-03-01 | -$754.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2020-03-31 | -$257.00K 10-Q · filed 2020-05-11 | -$396.00K derived: sum of 2 quarters · filed 2021-03-01 | -$680.00K derived: sum of 3 quarters · filed 2021-03-01 | -$900.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-12-31 | -$139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$423.00K derived: sum of 2 quarters · filed 2021-03-01 | -$643.00K derived: sum of 3 quarters · filed 2021-03-01 | -$801.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | -$284.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$504.00K derived: sum of 2 quarters · filed 2019-11-12 | -$662.00K 10-Q · filed 2019-11-12 | -$907.00K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2019-06-30 | -$220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$378.00K 10-Q · filed 2019-08-09 | -$623.00K derived: sum of 3 quarters · filed 2019-08-09 | -$963.00K derived: sum of 4 quarters · filed 2019-08-09 | |
| 2019-03-31 | -$158.00K 10-Q · filed 2019-05-10 | -$403.00K derived: sum of 2 quarters · filed 2019-05-10 | -$743.00K derived: sum of 3 quarters · filed 2019-05-10 | -$980.00K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-12-31 | -$245.00K derived: 10-K 12 month − 3 quarters · filed 2019-03-01 | -$585.00K derived: sum of 2 quarters · filed 2019-03-01 | -$822.00K derived: sum of 3 quarters · filed 2019-03-01 | -$939.00K 10-K · filed 2019-03-01 | |
| 2018-09-30 | -$340.00K 10-Q · filed 2018-11-09 | -$577.00K derived: sum of 2 quarters · filed 2018-11-09 | -$694.00K derived: sum of 3 quarters · filed 2018-11-09 | -$963.28K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2018-06-30 | -$237.00K 10-Q · filed 2018-11-09 | -$354.00K 10-Q · filed 2018-08-09 | -$623.28K derived: sum of 3 quarters · filed 2019-03-01 | -$808.49K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2018-03-31 | -$117.00K 10-Q · filed 2018-11-09 | -$386.28K derived: sum of 2 quarters · filed 2019-03-01 | -$571.49K derived: sum of 3 quarters · filed 2019-03-01 | -$806.03K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-12-31 | -$269.28K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$454.49K derived: sum of 2 quarters · filed 2019-03-01 | -$689.03K derived: sum of 3 quarters · filed 2019-03-01 | -$786.00K 10-K · filed 2019-03-01 | -$786.06K 10-K · filed 2018-03-15 |
| 2017-09-30 | -$185.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$419.76K derived: sum of 2 quarters · filed 2017-11-09 | -$516.72K 10-Q · filed 2017-11-09 | -$773.94K derived: sum of 4 quarters · filed 2018-03-15 | |
| 2017-06-30 | -$234.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$331.51K 10-Q · filed 2017-08-09 | -$588.74K derived: sum of 3 quarters · filed 2018-03-15 | -$773.71K derived: sum of 4 quarters · filed 2018-03-15 | |
| 2017-03-31 | -$96.97K 10-Q · filed 2017-05-10 | -$354.19K derived: sum of 2 quarters · filed 2018-03-15 | -$539.16K derived: sum of 3 quarters · filed 2018-03-15 | -$791.67K derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-12-31 | -$257.22K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$442.20K derived: sum of 2 quarters · filed 2018-03-15 | -$694.70K derived: sum of 3 quarters · filed 2018-03-15 | -$995.74K 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$184.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$437.48K derived: sum of 2 quarters · filed 2016-11-09 | -$738.52K 10-Q · filed 2016-11-09 | -$943.74K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2016-06-30 | -$252.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$553.54K 10-Q · filed 2016-08-09 | -$758.77K derived: sum of 3 quarters · filed 2017-03-16 | -$1.12M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2016-03-31 | -$301.04K 10-Q · filed 2016-05-10 | -$506.26K derived: sum of 2 quarters · filed 2017-03-16 | -$866.48K derived: sum of 3 quarters · filed 2017-03-16 | -$1.09M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-12-31 | -$205.22K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$565.44K derived: sum of 2 quarters · filed 2017-03-16 | -$788.81K derived: sum of 3 quarters · filed 2017-03-16 | -$1.03M 10-K · filed 2017-03-16 | |
| 2015-09-30 | -$360.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$583.59K derived: sum of 2 quarters · filed 2015-11-09 | -$824.23K 10-Q · filed 2015-11-09 | -$966.97K derived: sum of 4 quarters · filed 2016-03-15 | |
| 2015-06-30 | -$223.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$464.01K 10-Q · filed 2015-08-10 | -$606.75K derived: sum of 3 quarters · filed 2016-03-15 | -$817.61K derived: sum of 4 quarters · filed 2016-03-15 | |
| 2015-03-31 | -$240.64K 10-Q · filed 2015-05-11 | -$383.38K derived: sum of 2 quarters · filed 2016-03-15 | -$594.24K derived: sum of 3 quarters · filed 2016-03-15 | -$785.37K derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-12-31 | -$142.74K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$353.60K derived: sum of 2 quarters · filed 2016-03-15 | -$544.73K derived: sum of 3 quarters · filed 2016-03-15 | -$720.04K 10-K · filed 2016-03-15 | |
| 2014-09-30 | -$210.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$401.98K derived: sum of 2 quarters · filed 2014-11-14 | -$577.30K 10-Q · filed 2014-11-14 | -$3.01M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2014-06-30 | -$191.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | -$366.44K 10-Q · filed 2014-07-24 | -$2.79M derived: sum of 3 quarters · filed 2015-03-16 | -$3.11M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2014-03-31 | -$175.31K 10-Q · filed 2014-05-14 | -$2.60M derived: sum of 2 quarters · filed 2015-03-16 | -$2.92M derived: sum of 3 quarters · filed 2015-03-16 | -$3.21M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-12-31 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$2.75M derived: sum of 2 quarters · filed 2015-03-16 | -$3.03M derived: sum of 3 quarters · filed 2015-03-16 | -$3.30M 10-K · filed 2015-03-16 | |
| 2013-09-30 | -$319.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$602.43K derived: sum of 2 quarters · filed 2013-11-14 | -$872.83K 10-Q · filed 2013-11-14 | -$1.62M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2013-06-30 | -$283.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$553.45K 10-Q · filed 2013-08-09 | -$1.30M derived: sum of 3 quarters · filed 2014-03-07 | -$1.53M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2013-03-31 | -$270.40K 10-Q · filed 2013-05-14 | -$1.01M derived: sum of 2 quarters · filed 2014-03-07 | -$1.24M derived: sum of 3 quarters · filed 2014-03-07 | ||
| 2012-12-31 | -$744.36K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$972.02K derived: sum of 2 quarters · filed 2014-03-07 | -$1.66M 10-K · filed 2014-03-07 | ||
| 2012-09-30 | -$227.66K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$915.51K 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | -$687.85K 10-Q/A · filed 2012-09-07 | ||||
| 2011-12-31 | $0.00 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |